{"@context":["https://w3id.org/dats/context/sdo/dataset_sdo_context.jsonld","http://w3id.org/dats/context/obo/dataset_obo_context.jsonld"],"@type":"Project","acronym":"Pharma-Cog","description":"Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development","endDate":{"@context":"https://w3id.org/dats/context/sdo/date_info_sdo_context.jsonld","@type":"Date","date":"Thu, 31 Dec 2015 00:00:00 GMT","type":{"value":"end date","valueIRI":"http://semanticscience.org/resource/SIO_000036"}},"extraProperties":[{"category":"website","values":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"http://www.alzheimer-europe.org/Research/PharmaCog"}]}],"fundedBy":[{"@context":"https://w3id.org/dats/context/sdo/grant_sdo_context.jsonld","@type":"Grant","name":"IMI1 - Call 1 (Grant number 115009)"}],"identifier":{"@context":"https://w3id.org/dats/context/sdo/identifier_info_sdo_context.jsonld","@type":"Identifier","identifier":"f65ce9ec-5f11-11eb-917b-acde48001122"},"keywords":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Neurodegenerative diseases"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Alzheimer's disease"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Tools for predicting/monitoring safety"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Clinical trial design"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Drug discovery"}],"projectAssets":[],"projectLeads":[{"@context":"https://w3id.org/dats/context/sdo/person_sdo_context.jsonld","@type":"Person","affiliations":[{"@context":"https://w3id.org/dats/context/sdo/organization_sdo_context.jsonld","@type":"Organization","location":{"@context":"https://w3id.org/dats/context/sdo/place_sdo_context.jsonld","@type":"Place","postalAddress":"United Kingdom"},"name":"Glaxosmithkline Research And Development LTD"}],"email":"-","firstName":"Jill C","fullName":"Jill C Richardson","lastName":"Richardson","roles":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Project coordinator"}]},{"@context":"https://w3id.org/dats/context/sdo/person_sdo_context.jsonld","@type":"Person","affiliations":[{"@context":"https://w3id.org/dats/context/sdo/organization_sdo_context.jsonld","@type":"Organization","location":{"@context":"https://w3id.org/dats/context/sdo/place_sdo_context.jsonld","@type":"Place","postalAddress":"-"},"name":"Universit\u00e9 d'Aix-Marseille"}],"email":"-","firstName":"Isabelle","fullName":"Isabelle Amabile","lastName":"Amabile","roles":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Managing entity"}]}],"projectWebsite":"http://www.alzheimer-europe.org/Research/PharmaCog","startDate":{"@context":"https://w3id.org/dats/context/sdo/date_info_sdo_context.jsonld","@type":"Date","date":"Fri, 01 Jan 2010 00:00:00 GMT","type":{"value":"start date","valueIRI":"http://semanticscience.org/resource/SIO_000031"}},"title":"Pharma-Cog","types":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"}]}